Positivity to p-ANCA in patients with status epilepticus

4Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Status epilepticus (SE) may occur in the setting of several internal or neurologic diseases. Anti-neutrophilic cytoplasmic antibodies (ANCA) are a group of Ig that may be observed in patients with different autoimmune disorders but are particularly associated with systemic vasculitis named ANCA-associated-vasculities (AAV). We herein report 3 patients with SE and positivity to p-ANCA.Case presentation: One patient had a catastrophic evolution and died 5 months after disease onset. The other two patients had a good outcome and remained seizure-free at 30 months and 5 years of follow-up respectively.Conclusion: This report highlights the importance of considering ANCA dosage in patients with SE of unclear origin. © 2014 Ferlazzo et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Ferlazzo, E., Gambardella, A., Bellavia, M., Gasparini, S., Mumoli, L., Labate, A., … Aguglia, U. (2014). Positivity to p-ANCA in patients with status epilepticus. BMC Neurology, 14(1). https://doi.org/10.1186/1471-2377-14-148

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free